The purpose of this study is to compare the safety and efficacy of formulation BLI1100 to its vehicle in the treatment of moderate-severe acne vulgaris.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
233
BLI110 topical cream
Vehicle topical cream
Center for Dermatology Clincal Research
Fremont, California, United States
percent reduction of total acne lesion counts
Time frame: 12 weeks
Investigator's Global Assessment
Rating of overall facial acne on a 4 point scale (0=clear to 4=severe) performed by a blinded investigator.
Time frame: 12
Change in serum chemistry
Time frame: 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Dermatology Research Associates
Los Angeles, California, United States
Dermatology Specialists
Oceanside, California, United States
Horizons Clinical Research Center
Denver, Colorado, United States
North Florida Dermatology Associates
Jacksonville, Florida, United States
Ameriderm Research
Ormond Beach, Florida, United States
Atlanta Dermatology, Vein and Research Center
Alpharetta, Georgia, United States
Peachtree Dermatology Associates Research Center
Atlanta, Georgia, United States
Northwest Clinical Trials
Nampa, Idaho, United States
The Indiana Clinical Trials Center
Plainfield, Indiana, United States
...and 10 more locations